Diagnamed Holdings Corp.
DMED
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 301.80K | 343.20K | 445.10K | 471.30K | 571.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 459.20K | 495.70K | 579.30K | 610.90K | 729.00K |
| Operating Income | -459.20K | -495.70K | -579.30K | -610.90K | -729.00K |
| Income Before Tax | -492.80K | -367.80K | -451.40K | -434.60K | -660.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.49 | -0.37 | -0.45 | -0.43 | -0.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -492.80K | -367.80K | -451.40K | -434.60K | -660.50K |
| EBIT | -459.20K | -495.70K | -579.30K | -610.90K | -729.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 320.92M | 320.21M | 320.23M | 319.51M | 316.59M |
| Average Diluted Shares Outstanding | 320.92M | 320.21M | 320.23M | 319.51M | 316.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
